-       Report 
   - September 2025
    -  72 Pages 
    Global
   
   From       €3500EUR$4,171USD£3,177GBP 
                -       Report 
   - July 2025
    -  112 Pages 
    Global
   
   From       €3500EUR$4,171USD£3,177GBP 
                  -       Report 
   - August 2025
    -  150 Pages 
    Global
   
   From       €3018EUR$3,358USD£2,647GBP 
      €3550EUR$3,950USD£3,114GBP 
                  -       Report 
   - August 2025
    -  150 Pages 
    Global
   
   From       €3018EUR$3,358USD£2,647GBP 
      €3550EUR$3,950USD£3,114GBP 
                  -       Training 
   - December 2025
    -  2 Days 
    Global
   
        €1533EUR$1,765USD£1,299GBP 
      €1769EUR$2,037USD£1,499GBP 
                   -       Report 
   - July 2025
    -  140 Pages 
    Global
   
   From       €3705EUR$4,123USD£3,250GBP 
      €4359EUR$4,850USD£3,823GBP 
                -       Report 
   - July 2025
    -  150 Pages 
    United States
   
   From       €5348EUR$5,950USD£4,690GBP 
                -       Report 
   - August 2024
    -  381 Pages 
    Global
   
   From       €4313EUR$4,799USD£3,783GBP 
                -       Report 
   - June 2023
    -  364 Pages 
    Global
   
   From       €4662EUR$5,368USD£3,950GBP 
                -       Report 
   - October 2022
    -  194 Pages 
    Global
   
   From       €4494EUR$5,000USD£3,941GBP 
                -       Report 
   - January 2024
    -  213 Pages 
    Global
   
   From       €4179EUR$4,650USD£3,665GBP 
                -       Report 
   - August 2024
    -  100 Pages 
    Global
   
   From       €5348EUR$5,950USD£4,690GBP 
                -       Report 
   - October 2024
    -  80 Pages 
    Vietnam
   
   From       €3236EUR$3,600USD£2,838GBP 
                -       Report 
   - January 2024
    -  200 Pages 
    Global
   
   From       €3730EUR$4,150USD£3,271GBP 
                -       Report 
   - January 2024
    -  200 Pages 
    Global
   
   From       €3730EUR$4,150USD£3,271GBP 
                  -       Report 
   - July 2024
    -  150 Pages 
    Global
   
   From       €2696EUR$3,000USD£2,365GBP 
      €3371EUR$3,750USD£2,956GBP 
                  -       Report 
   - November 2023
    -  30 Pages 
    Global
   
   From       €1977EUR$2,200USD£1,734GBP 
      €2472EUR$2,750USD£2,168GBP 
                  -       Report 
   - November 2023
    -  30 Pages 
    Global
   
   From       €2337EUR$2,600USD£2,049GBP 
      €2921EUR$3,250USD£2,562GBP 
                -       Report 
   - February 2024
    -  115 Pages 
    Global
   
   From       €4269EUR$4,750USD£3,744GBP 
                -       Report 
   - January 2025
    -  85 Pages 
    Saudi Arabia
   
   From       €3146EUR$3,500USD£2,759GBP 
             
         The Vaccine Adjuvant market is a subset of the Vaccines market, which is composed of products that are used to enhance the effectiveness of vaccines. Vaccine adjuvants are substances that are added to vaccines to increase the body's immune response to the vaccine. Adjuvants can be either natural or synthetic, and can be used to increase the potency of a vaccine, reduce the amount of antigen needed, or to extend the duration of the vaccine's effectiveness. Vaccine adjuvants are used in a variety of    vaccines, including those for influenza, hepatitis, and human papillomavirus.
Some companies in the Vaccine Adjuvant market include GlaxoSmithKline, Merck, Sanofi, and Novartis. Show Less   Read more